In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for BPC 157: Prohibited peptide and unapproved drug in supplements FDA mulls compounding for peptides previously flagged over safety risks BioSpace The Peptide Craze Ground Truths I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions